Our data suggest that HR+ breast cancer patients with lymph node metastasis lack tumor-specific CD8 T cells with capacity to infiltrate the tumor at significant levels. The gene discussed is CD8A; the disease is metastatic malignant neoplasm in the lymph nodes.